1. Articles in category: Other Business News

    1-24 of 1215 1 2 3 4 ... 49 50 51 »

    1. LighTopTech Corp. Receives Small Business Innovation Research Phase II Award from the US National Institutes of Health (NIH)

      Explore Optical Coherence Tomography News Ophthalmology , Funding , Other Business News
      LighTopTech Corp. Receives Small Business Innovation Research Phase II Award from the US National Institutes of Health (NIH)

      LighTopTech Corp., an upstate New York-based company building innovative optical instruments to bring to market disruptive imaging technologies industrial and medical fields, has been awarded a Phase II Small Business Innovation Research (SBIR) award by the National Eye Institute of the National Institutes of Health (NIH). The NIH Phase II award will allow LighTopTech to develop the first 3D high-definition imaging instrument based on Gabor-Domain Optical Coherence Microscopy (GDOCM) for quantitative assessment of corneal tissue at eye banks. LighTopTech will develop and apply machine learning methods to automatically segment the endothelial cells of the cornea and count them to assess ...

      Read Full Article
      Mentions: National Institutes of Health Jannick P. Rolland LighTopTech

    2. Perimeter Medical Imaging Receives $7.44 Million CPRIT Grant To Further Develop AI ImgAssist Technology at Leading Cancer Centers in Texas

      Explore Optical Coherence Tomography News Funding , Other Business News
      Perimeter Medical Imaging Receives $7.44 Million CPRIT Grant To Further Develop AI ImgAssist Technology at Leading Cancer Centers in Texas

      Perimeter Medical Imaging , a medical device company, today announces that it has received a $7.44 million grant from CPRIT, a leading state body funding cancer research, to continue developing its artificial intelligence technology that can help surgeons identify if cancer is still present post-tumor removal surgery. The sponsored technology, known as OTIS™, is designed to provide real-time information during breast cancer surgery. The platform’s ability to deliver ultra-high resolution and sub-surface image volumes across the surface of the removed tissue allows surgeons to assess if they have achieved the successful removal of the entire tumor. Should a surgeon ...

      Read Full Article
      Mentions: Baylor College of Medicine Perimeter Medical Imaging

    3. Eye in the Sky: Video Game to Improve the Automation of Interpreting OCT Scans for the diagnosis and treatment of AMD

      Explore HuMIn Game Lab Ophthalmology , Other Business News
      Eye in the Sky: Video Game to Improve the Automation of Interpreting OCT Scans for the diagnosis and treatment of AMD

      Optical coherence tomography (OCT) scans can be used to diagnose and evaluate the effectiveness of various treatments and therapies for patients with Age-Related Macular Degeneration (AMD), the leading cause of severe visual impairment in the developed world. While there are treatments for some forms of wet AMD there is nothing to help the vast majority of patients suffering from the dry or degenerative form of AMD. One of the major obstacles in the development of an effective treatment is the inability to detect objective criteria that would either herald further progression of the disease or identify aspects that suggest improvement ...

      Read Full Article

    4. Merit Medical Reports Earnings for Quarter Ended March 31, 2020, Withdraws FY 2020 Guidance

      Explore biospace.com Gastroenterology , Other Business News
      Merit Medical Reports Earnings for Quarter Ended March 31, 2020, Withdraws FY 2020 Guidance

      Merit Medical Systems, Inc. (NASDAQ: MMSI), a leading manufacturer and marketer of proprietary disposable devices used in interventional, diagnostic and therapeutic procedures, particularly in cardiology, radiology, oncology, critical care and endoscopy, today announced revenue of $243.5 million for the quarter ended March 31, 2020, an increase of 2.2% over revenue of $238.3 million for the quarter ended March 31, 2019....$1.4M Represents write-off of inventory related to our distribution agreement with NinePoint Medical, Inc.

      Read Full Article
      Mentions: NinePoint Medical

    6. ZEISS Medical Technology Announces Changes in Ophthalmic Devices Executive Leadership

      Explore Optical Coherence Tomography News Ophthalmology , Other Business News
      ZEISS Medical Technology Announces Changes in Ophthalmic Devices Executive Leadership

      Effective 1 May 2020, Jim Mazzo will retire from his position as President Ophthalmic Devices and Head of the Ophthalmic Devices Strategic Business Unit for ZEISS. He will continue to support ZEISS as an advisor. With over forty years in the ophthalmic industry, Jim has successfully transformed ZEISS Global Ophthalmic Devices as the number two industry leader in Ophthalmology by creating a strong customer focused organization within his three plus years with ZEISS. "I am very proud of what we have accomplished for customers and employees and pleased to hand over responsibility to Euan and the team. With this team ...

      Read Full Article
      Mentions: University of London Carl Zeiss Meditec Ludwin Monz

    7. Cylite receives ISO 13485 Certification

      Explore Optical Coherence Tomography News Ophthalmology , Other Business News
      Cylite receives ISO 13485 Certification

      Cylite Pty Ltd, a developer and manufacturer of 4 th Generation OCT systems for Ophthalmology and Optometry, is pleased to announce that it has been awarded International Organization for Standardization (ISO) 13485:2016 certification for medical device quality management systems (QMS) following review by BSI. ISO 13485:2016 is an internationally recognized quality standard specific to the medical device industry. ISO 13485 certification affirms to Cylite’s patients and partners that the company is providing the best quality management systems and regulatory compliance for its 4 th generation OCT platform. Yameena Ratnayake, Cylite’s Quality Manager commented,” We are very ...

      Read Full Article
      Mentions: Cylite

    8. Avinger Announces Publication of SCAN Clinical Study in Peer-Reviewed Journal

      Explore Industry Cardiology , Other Business News
      Avinger Announces Publication of SCAN Clinical Study in Peer-Reviewed Journal

      vinger, Inc. (NASDAQ:AVGR), a commercial-stage medical device company marketing the first and only intravascular image-guided, catheter-based system for diagnosis and treatment of Peripheral Artery Disease (PAD), today announced that the results of its SCAN clinical study have been published in the peer-reviewed journal BMC Medical Imaging. SCAN is a prospective, non-inferiority, post-market study comparing optical coherence tomography (OCT) with intravascular ultrasound (IVUS) as a diagnostic imaging tool in the peripheral arteries. Study results showed that OCT imaging with Avinger's Pantheris system demonstrated statistical superiority or equivalence to IVUS on all parameters evaluated. While OCT has been documented to ...

      Read Full Article
      Mentions: FDA Avinger

    9. Kylee Hall joins Cylite as VP Sales and Marketing

      Explore Optical Coherence Tomography News Ophthalmology , Other Business News
      Kylee Hall joins Cylite as VP Sales and Marketing

      ylite Pty Ltd, a company developing the next generation of diagnostic OCT systems for Ophthalmology and Optometry, is pleased to announce the appointment of Kylee Hall as Vice President, Sales and Marketing. Ms Hall is a medical device industry expert and brings more than 13 years of senior leadership in sales, marketing and corporate management. She has a record of accomplishment in executing best practice business, sales and marketing strategies in Ophthalmic and Surgical devices. "I am delighted to welcome Kylee to the Cylite executive team,” stated Dr. Steve Frisken, Chief Executive Officer of Cylite. “I am confident that her ...

      Read Full Article
      Mentions: Cylite

    10. Merit Medical Reports Earnings for Fourth Quarter and Year Ended December 31, 2019, Gives FY 2020 Guidance

      Explore GlobeNewswire, Inc. Other Business News
      Merit Medical Reports Earnings for Fourth Quarter and Year Ended December 31, 2019, Gives FY 2020 Guidance

      Merit noted that during the fourth quarter of 2019, it recorded an impairment expense of approximately $20.5 million related to its arrangement with NinePoint Medical, Inc., in which Merit fully impaired its loan to NinePoint and its option to purchase the outstanding equity of NinePoint. In addition, Merit recorded a write-off of $1.6 million of accrued interest related to the loan to NinePoint.  

      Read Full Article
      Mentions: NinePoint Medical

    11. Conavi Medical and Japan Lifeline Announce MHLW Approval of Novasight Hybrid Intravascular Imaging System for Japanese Market

      Explore Optical Coherence Tomography News Cardiology , Other Business News
      Conavi Medical and Japan Lifeline Announce MHLW Approval of Novasight Hybrid Intravascular Imaging System for Japanese Market

      Conavi Medical Inc. and Japan Lifeline are pleased to announce that they have received regulatory approval from the Ministry of Health, Labor and Welfare (MHLW) in Japan for the Novasight Hybrid TM intravascular imaging system. The Novasight Hybrid system is the world’s first clinical system capable of providing both intravascular ultrasound (IVUS) and optical coherence tomography (OCT) on a single imaging catheter. The system also has Health Canada approval and FDA 510(k) clearance in the USA. Japan Lifeline is the exclusive distributor for this technology in Japan. Dr. Brian Courtney, Conavi Medical’s Chief Executive Officer, comments that ...

      Read Full Article
      Mentions: FDA Brian K. Courtney Conavi Medical Inc.

    12. AI-based retinal fluid analytics of serial Notal Vision home OCT images offers insights into retinal disease dynamics

      Explore Optical Coherence Tomography News Ophthalmology , Other Business News
      AI-based retinal fluid analytics of serial Notal Vision home OCT images offers insights into retinal disease dynamics

      Longitudinal data on retinal imaging of age-related macular degeneration (AMD) patients using the final form factor of Notal Vision’s home OCT (NOTAL-OCT V3.0) was presented at the Angiogenesis, Exudation, and Degeneration meeting in Miami. The pipeline technology is designed to use home-based, patient-initiated retinal OCT scans to support the management of patients with exudative AMD, complementing existing standard of care as well as emerging longer acting drugs and drug delivery systems. “This is the first time nano-liter scale quantities of intra- and subretinal fluid have been tracked over time based on home OCT images and deep learning retinal ...

      Read Full Article
      Mentions: FDA Kester Nahen Notal Vision

    13. Optos eyes continued global growth with new eyecare technology made in Scotland

      Explore Herald Scotland Ophthalmology , Other Business News
      Optos eyes continued global growth with new eyecare technology made in Scotland

      This March, the company will launch an addition to its flagship technology called optical coherence tomography (OCT), which uses light waves to take cross-section pictures of a patient’s retina. “On our latest device, we’re the first to allow an OCT scan to take place anywhere on the retina,” Kennedy explained. “That’s been developed here in Scotland and it allows doctors to see different layers, a bit like a CT scan, across the retina, whereas traditional devices typically only look at the central area. OCT scans are really important for many eye diseases as they allow you to ...

      Read Full Article
      Mentions: University of Sheffield Optos University of Dundee

    14. PhotoniCare's TOMi Scope takes Top Prize at SPIE and Photonics Media Prism Awards

      Explore Optical Coherence Tomography News Otolaryngology , Other Business News
      PhotoniCare's TOMi Scope takes Top Prize at SPIE and Photonics Media Prism Awards

      PhotoniCare, Inc., a company dedicated to revolutionizing healthcare by providing physicians with better diagnostic tools, today announced the company’s TOMi ™ Scope was awarded best healthcare product at the 12th Annual Prism Awards in San Francisco. The Prism Awards is an annual international competition that honors the best new optics and photonics products on the market. Since 2008, SPIE, along with media partner Photonics Media, has presented awards to companies and individuals that are creating products that make a difference, solve problems, and improve life through photonics. The Prism Awards reflect the exponential growth, exciting developments, and rich technical innovations ...

      Read Full Article
      Mentions: Stephen A. Boppart FDA Ryan L. Shelton

    15. Acucela Meets with NASA and TRISH for Phase 1 Update for SS-OCT Project

      Explore Optical Coherence Tomography News Ophthalmology , Other Business News
      Acucela Meets with NASA and TRISH for Phase 1 Update for SS-OCT Project

      Acucela Inc. (“Acucela”), a clinical-stage ophthalmology company and wholly-owned subsidiary of Kubota Pharmaceutical Holdings Co., Ltd. (Tokyo 4596), announced today that the company was invited to meet with NASA and the Translational Research Institute for Space Health (TRISH) *1 to present on January 30, 2020 the status of its Swept Source-OCT *2 (“SS-OCT”) device being developed for NASA’s Deep Space missions. The purpose of the meeting was to review and discuss progress of this Phase 1 project with the engineers, basic and medical scientists and program managers from NASA and TRISH. Additionally, a demonstration of the Phase 1 device ...

      Read Full Article
      Mentions: Massachusetts Institute of Technology California Institute of Technology Baylor College of Medicine

    16. New OCT Image Analysis Capabilities From Wasatch Photonics

      Explore Optical Coherence Tomography News Other Business News
      New OCT Image Analysis Capabilities From Wasatch Photonics

      Wasatch Photonics is pleased to announce the expansion of our WP OCT Software and software development kits with new features to facilitate the translation of images into actionable information. These OCT image analysis capabilities lower the barrier to use for OCT by non-experts, and offer the potential for automated analysis of images in real time. The new features include image enhancement, layer segmentation, and classification functions based on powerful machine learning algorithms, and may be accessed from our user-friendly OCT image acquisition software or via our software development kits (SDKs). To help you see the possibilities, we have trained our ...

      Read Full Article
      Mentions: Wasatch Photonics

    18. New Device Performs 3D “Optical Biopsies” Of Skin

      Explore Optical Coherence Tomography News Dermatology , Other Business News
      New Device Performs 3D “Optical Biopsies” Of Skin

      DAMAE Medical and NKT Photonics have worked together under the Eurostar financing program to combine the cutting-edge Line-field Confocal Optical Coherence Tomography (LC-OCT) imaging technology, developed by DAMAE Medical, with the innovative supercontinuum laser technology provided by NKT Photonics. With a broadband SuperK white light laser as a key component, DAMAE Medical has developed an in vivo skin imaging device which performs “optical biopsies” based on the new LC-OCT technology. This unique technique couples the technological advantages of OCT and confocal microscopy: high resolution at high penetration depth. The broadband near-infrared light from the laser combined with high aperture microscope ...

      Read Full Article
      Mentions: Arnaud Dubois NKT Photonics Damae Medical

    19. Avinger Enrolls First Patient in IMAGE-BTK Clinical Study Evaluating Safety and Efficacy Endpoints for Pantheris SV

      Explore Optical Coherence Tomography News Cardiology , Other Business News
      Avinger Enrolls First Patient in IMAGE-BTK Clinical Study Evaluating Safety and Efficacy Endpoints for Pantheris SV

      Avinger, Inc. (Nasdaq:AVGR), a commercial-stage medical device company marketing the first and only intravascular image-guided, catheter-based system for diagnosis and treatment of Peripheral Artery Disease (PAD), today announced the initiation of the IMAGE-BTK clinical study for its Pantheris SV image-guided atherectomy system. IMAGE-BTK is a post-market trial designed to evaluate safety and efficacy endpoints for Pantheris SV in the treatment of peripheral artery lesions below-the-knee (BTK). Dr. Thomas Davis, an interventional cardiologist at Eastlake Cardiovascular, P.C. in Saint Claire Shores, Michigan, enrolled the first patient in IMAGE-BTK and will serve as the principal investigator of the study. After ...

      Read Full Article
      Mentions: Avinger

    21. Avinger Announces Successful First Procedures in Europe with Ocelaris Chronic Total Occlusion (CTO) Image-Guided Crossing Device

      Explore Optical Coherence Tomography News Cardiology , Other Business News
      Avinger Announces Successful First Procedures in Europe with Ocelaris Chronic Total Occlusion (CTO) Image-Guided Crossing Device

      Avinger, Inc. (NASDAQ:AVGR), a commercial-stage medical device company marketing the first and only intravascular image-guided, catheter-based system for diagnosis and treatment of Peripheral Artery Disease (PAD), today announced the first clinical experiences with the Ocelaris next-generation CTO crossing system utilizing Avinger's proprietary image-guided technology platform. Dr. Arne Schwindt, a vascular surgeon at St. Franziskus Hospital Münster, and Dr. Michael Lichtenberg, an interventional angiologist at Klinikum Hochsauerland, Arnsberg, used Ocelaris in multiple procedures across a variety of different lesion types and anatomy both above and below the knee. Avinger plans to continue supporting first cases with Ocelaris at ...

      Read Full Article
      Mentions: FDA Avinger Arne G. Schwindt

    22. CPT codes for home OCT established

      Explore Optical Coherence Tomography News Ophthalmology , Other Business News
      CPT codes for home OCT established

      The AMA’s CPT® Editorial Panel has accepted three new category III codes for reporting patient-initiated remote retinal OCT scans, facilitated by Notal Vision’s home-based OCT pipeline technology Notal Vision, Inc., a privately held ophthalmic diagnostic services company focused on advancing eye care with precision medicine by extending disease management from the clinic to the home, announced today that the American Medical Association’s (AMA) Current Procedural Terminology (CPT) Editorial Panel has established three new Category III codes (0604T, 0605T, 0606T) to report patient-initiated remote retinal optical coherence tomography (OCT) scans, which is performed using Notal Vision’s home-based ...

      Read Full Article
      Mentions: Kester Nahen Notal Vision

    23. PhotoniCare Announces FDA Clearance for First-In-Class Technology for Imaging the Ear

      Explore Optical Coherence Tomography News Otolaryngology , Clinical Trials , Other Business News
      PhotoniCare Announces FDA Clearance for First-In-Class Technology for Imaging the Ear

      PhotoniCare, Inc., a company dedicated to revolutionizing healthcare by providing physicians with better diagnostic tools, today announced that the U.S. Food & Drug Administration (FDA) has granted 510(k) clearance for its TOMi ™ Scope for non-invasive imaging of the middle ear. Using optical coherence tomography (OCT) high resolution depth imaging, TOMi Scope helps to determine the presence or absence of fluid in the middle ear and to characterize the fluid type. According to clinical guidelines, the presence of fluid in the middle ear is a primary indicator for determining infection. Designed to eliminate subjectivity and speculation, TOMi Scope allows physicians ...

      Read Full Article
      Mentions: National Institutes of Health FDA Ryan L. Shelton

    24. Acucela to Participate in Biotech Showcase™ 2020

      Explore businesswire.com Ophthalmology , Other Business News
      Acucela to Participate in Biotech Showcase™ 2020

      Retinal Health Remote Monitoring Device (eyeMO®). A home-based, patient self-monitoring miniature optical coherence tomography (OCT) device, eyeMO® is designed to detect nascent disease progression and support patient re-treatment prior to irreversible vision loss due to disease progression from neovascular retinal diseases.

      Read Full Article
      Mentions: Acucela
    1-24 of 1215 1 2 3 4 ... 49 50 51 »
  1. Search:

  2. Categories

    1. Applications:

      Art, Cardiology, Dentistry, Dermatology, Developmental Biology, Gastroenterology, Gynecology, Microscopy, NDE/NDT, Neurology, Oncology, Ophthalmology, Other Non-Medical, Otolaryngology, Pulmonology, Urology

    2. Business News:

      Acquisition, Clinical Trials, Funding, Other Business News, Partnership, Patents

    3. Technology:

      Broadband Sources, Probes, Tunable Sources

    4. Miscellaneous:

      Jobs & Studentships, Student Theses, Textbooks

  4. Popular Articles

  5. Organizations in the News

    1. (1 articles) National Institutes of Health

  6. People in the News

    1. (1 articles) Jannick P. Rolland

  7. OCT Companies in the News

    1. (1 articles) LighTopTech